DAVITA INC (DVA)

US23918K1088 - Common Stock

142.265  +2.51 (+1.8%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

DAVITA INC

NYSE:DVA (5/2/2024, 8:33:02 AM)

142.265

+2.51 (+1.8%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap12.48B
Shares
PE19.22
Fwd PE15.76
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

DVA Daily chart

Company Profile

DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 70,000 full-time employees. The firm provides kidney care services in the United States. The firm's operations are comprised of its U.S. dialysis and related lab services business (its U.S. dialysis business), its U.S. integrated kidney care business, its U.S. other ancillary services and its international operations (its ancillary services). The U.S. dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, and end-stage kidney disease (ESKD). Its services include outpatient hemodialysis services, hospital inpatient hemodialysis services, and home-based dialysis services. The ancillary services consist of integrated kidney care services, physician services, clinical research programs, and transplant software business, as well as international operations. The firm operates approximately 2,724 outpatient dialysis centers in the United States.

Company Info

DAVITA INC

2000 16th St

Denver COLORADO 80202

P: 13105362668

CEO: Javier J. Rodriguez

Employees: 70000

Website: https://www.davita.com/

DVA News

News Imagea day ago - InvestorPlace3 Healthcare Stocks With the Potential to Triple Your Investment by 2026

Learn how these three healthcare stocks offer sharp opportunities in pharmaceuticals, healthcare services, and biotechnology.

News Image5 days ago - The Motley FoolWarren Buffett's 3 Best-Performing Stocks So Far in 2024: Are They Buys Now?

These high-flying Buffett stocks could be attractive to different kinds of investors.

News Image10 days ago - Investor's Business DailyFord, Nvidia Among Top S&P 500 Stocks Monday; Tesla Extends Losses

Ford, United Airlines and megacap AI stock Nvidia were big-cap winners.

News Image10 days ago - ChartmillWhat's going on in today's session: S&P500 movers

Which S&P500 stocks are moving on Monday?

News Image10 days ago - DaVitaDaVita's Global Operations Powered by 100% Renewable Energy

/PRNewswire/ -- By 2025, DaVita (NYSE: DVA), a leading provider of kidney care services, expects to match 100% of its electricity use across its global...

News Image14 days ago - Investor's Business DailyHow The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher

ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use.

DVA Twits

Here you can normally see the latest stock twits on DVA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example